Translational utility of experimental autoimmune encephalomyelitis: recent developments
Andre Ortlieb Guerreiro-Cacais, Hannes Laaksonen, Sevasti Flytzani, Marie N'diaye, Tomas Olsson, Maja Jagodic Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden Abstract: Multiple sclerosis (MS) is a complex aut...
Guardado en:
Autores principales: | Guerreiro-Cacais AO, Laaksonen H, Flytzani S, N’diaye M, Olsson T, Jagodic M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e1f092adaa3644159f00982c3b1a8ce8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Dhaiban S, et al.
Publicado: (2020) -
Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens
por: Al-ani MR, et al.
Publicado: (2020) -
Current perspectives on the role of IL-17 in autoimmune disease
por: Hisakata Yamada
Publicado: (2010) -
Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity?
por: Thomas Hügle
Publicado: (2011) -
Topical Administration of 15-Deoxy-Δ12,14-Prostaglandin J2 Using a Nonionic Cream: Effect on UVB-Induced Skin Oxidative, Inflammatory, and Histopathological Modifications in Mice
por: Clovis M. Kumagai, et al.
Publicado: (2021)